4//SEC Filing
Hassard James 4
Accession 0001209191-24-004612
CIK 0001658247other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 8:18 PM ET
Size
7.4 KB
Accession
0001209191-24-004612
Insider Transaction Report
Form 4
Hassard James
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-03-04+17,000→ 31,000 total - Award
Stock Option (right to buy)
2024-03-04+63,000→ 63,000 totalExercise: $43.51Exp: 2034-03-03→ Common Stock (63,000 underlying)
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2025.
- [F2]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 4, 2024.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001799357
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 8:18 PM ET
- Size
- 7.4 KB